QTORIN Trademark

Trademark Overview

On Thursday, February 7, 2019, a trademark application was filed for QTORIN with the United States Patent and Trademark Office. The USPTO has given the QTORIN trademark a serial number of 88292178. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by Palvella Therapeutics, Inc.. The QTORIN trademark is filed in the Pharmaceutical Products and Transportation & Storage Services categories with the following description:

Delivery of goods, namely, delivery of chemical delivery systems for a medical topical gel application

Chemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates the delivery of rapamycin and macrolides of similar chemical structure acting on mammalian targets of rapamycin, by enabling and facilitating the placement of agents that act on mammalians for the delivery of rapamycin and macrolides of similar chemical structure in and on the skin
qtorin

General Information

Serial Number88292178
Word MarkQTORIN
Filing DateThursday, February 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesDelivery of goods, namely, delivery of chemical delivery systems for a medical topical gel application
Goods and ServicesChemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates the delivery of rapamycin and macrolides of similar chemical structure acting on mammalian targets of rapamycin, by enabling and facilitating the placement of agents that act on mammalians for the delivery of rapamycin and macrolides of similar chemical structure in and on the skin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateThursday, February 28, 2019
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePalvella Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NamePalvella Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWayne, PA 19087

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2022SOU EXTENSION 5 GRANTED
Thursday, March 3, 2022SOU EXTENSION 5 FILED
Monday, March 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 1, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 1, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2021SOU EXTENSION 4 GRANTED
Thursday, August 19, 2021SOU EXTENSION 4 FILED
Thursday, August 19, 2021SOU TEAS EXTENSION RECEIVED
Friday, March 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 3, 2021SOU EXTENSION 3 GRANTED
Wednesday, March 3, 2021SOU EXTENSION 3 FILED
Wednesday, March 3, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 2 GRANTED
Monday, August 10, 2020SOU EXTENSION 2 FILED
Monday, August 10, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, March 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2020SOU EXTENSION 1 GRANTED
Monday, March 2, 2020SOU EXTENSION 1 FILED
Monday, March 2, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2019ASSIGNED TO LIE
Wednesday, May 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 13, 2019EXAMINER'S AMENDMENT ENTERED
Monday, May 13, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 13, 2019EXAMINERS AMENDMENT E-MAILED
Monday, May 13, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, April 20, 2019ASSIGNED TO EXAMINER
Thursday, February 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 11, 2019NEW APPLICATION ENTERED

Related Keywords

qtorin delivery chemical rapamycin macrolides structure medical similar acting mammalian facilitating